Home » Newsletters » BioWorld

BioWorld

Aug. 5, 1993

View Archived Issues

SCIOS NOVA, MCNEIL INK CO-MARKETING PACT

SOMATOGEN COMPLETES DOSE-ESCALATION REGIMEN

TARGETED GENETICS TO COLLABORATE WITH JOHNS HOPKINS

VARMUS OFFICIALLY NAMED TO HEAD NIH

QUIDEL TO ACQUIRE FERTILITY PRODUCT LINE

BIO ENDORSES CLINTON'S BUDGET

FOURTH FIAU PATIENT DIES

GENSIA FILES FOR APPROVALS FOR GENESA

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...